{"id":"regadenoson-central-central","safety":{"commonSideEffects":[{"rate":"10-20%","effect":"Headache"},{"rate":"5-10%","effect":"Dizziness"},{"rate":"5-10%","effect":"Nausea"}]},"_chembl":{"chemblId":"CHEMBL3989695","moleculeType":"Small molecule","molecularWeight":"408.38"},"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"Regadenoson central works by stimulating the adenosine A2A receptor, which leads to vasodilation and increased blood flow to the heart. This allows for improved myocardial perfusion and oxygenation, particularly during stress testing. The increased blood flow can help to identify coronary artery disease and other cardiac conditions.","oneSentence":"Regadenoson central acts as an adenosine A2A receptor agonist, increasing coronary blood flow.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T00:52:19.433Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Nuclear stress test for coronary artery disease"}]},"trialDetails":[{"nctId":"NCT05081115","phase":"","title":"Stress Echo 2030: the Novel ABCDE-(FGLPR) Protocol to Define the Future of Imaging","status":"RECRUITING","sponsor":"Fatebenefratelli Hospital","startDate":"2021-04-01","conditions":"Coronary Artery Disease, Heart Failure, Hypertrophic Cardiomyopathy","enrollment":10000},{"nctId":"NCT02560467","phase":"NA","title":"Perfusion Imaging With Myocardial Contrast Echocardiography in HCM","status":"UNKNOWN","sponsor":"Oregon Health and Science University","startDate":"2015-12-01","conditions":"Hypertrophic Cardiomyopathy","enrollment":10},{"nctId":"NCT01618669","phase":"PHASE3","title":"A Study to Assess Regadenoson Administration Following an Inadequate Exercise Stress Test as Compared to Regadenoson Alone for Myocardial Perfusion Imaging (MPI) Using Single Photon Emission Computed Tomography (SPECT)","status":"COMPLETED","sponsor":"Astellas Pharma Global Development, Inc.","startDate":"2012-06","conditions":"Coronary Artery Disease (CAD)","enrollment":1147},{"nctId":"NCT01150578","phase":"","title":"Evaluation of Myocardial Ischemia Using Standard Single Photon Emission Computed Tomography (SPECT) With Regadenoson and Simultaneous Cardiac Echocardiography","status":"UNKNOWN","sponsor":"Aiden Abidov","startDate":"2011-12","conditions":"Myocardial Ischemia","enrollment":380},{"nctId":"NCT01809743","phase":"PHASE3","title":"Regadenoson and Adenosine","status":"COMPLETED","sponsor":"Lokien van Nunen","startDate":"2013-01","conditions":"Coronary Artery Disease","enrollment":100},{"nctId":"NCT01778218","phase":"PHASE2","title":"A Single Center Study to Establish the Imaging Protocol of 99mTc-EC-DG in Evaluating the Presence and Severity of Coronary Artery Disease (CAD)","status":"COMPLETED","sponsor":"Cell>Point LLC","startDate":"2013-01","conditions":"Coronary Artery Disease","enrollment":2},{"nctId":"NCT00862641","phase":"PHASE4","title":"A Study of the Safety and Tolerance of Regadenoson in Subjects With Asthma or Chronic Obstructive Pulmonary Disease","status":"COMPLETED","sponsor":"Astellas Pharma Inc","startDate":"2009-04","conditions":"Asthma, Coronary Artery Disease, Pulmonary Disease, Chronic Obstructive","enrollment":1009}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_3","status":"active","brandName":"Regadenoson central -central","genericName":"Regadenoson central -central","companyName":"Lokien van Nunen","companyId":"lokien-van-nunen","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Regadenoson central acts as an adenosine A2A receptor agonist, increasing coronary blood flow. Used for Nuclear stress test for coronary artery disease.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}